64 Results for "

HIF-2

" in MedChemExpress (MCE) Product Catalog:
Products (64)

64 Results for "HIF-2" in MCE Product Catalog:

Cat. No.: HY-111547
CAS No.: 874590-32-6
Purity:  99.51%
Research Areas:  

Cancer

M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research .
loading...
    loading...
Cat. No.: HY-P10221A
Research Areas:  

Cancer

Cyclo(CKLIIF) TFA is an inhibitor of HIF-1α and HIF-2α. The KD values of Cyclo(CKLIIF) TFA for the PAS-B domains of HIF1-α and HIF2-α are 2.6 μM and 2.2 μM, respectively. Cyclo(CKLIIF) TFA disrupts the protein-protein interaction between HIF-1α and HIF-1β. Cyclo(CKLIIF) TFA can be used in cancer research .
loading...
    loading...
Cat. No.: HY-177078
CAS No.: 2925064-31-7
Research Areas:  

Cancer

Davotifan (Compound A17) is a bicyclic compound. Davotifan is an inhibitor of HIF-2α. Davotifan can be studied in research for HIF-2α-related cancer .
loading...
    loading...
Cat. No.: HY-B0219R
CAS No.: 315-30-0
Allopurinol (Standard) is the analytical standard of Allopurinol. This product is intended for research and analytical applications. Allopurinol is a potent and orally active xanthine oxidase inhibitor with an IC50 value of 0.2-50 μM. Allopurinol can be used in the research of hyperuricemia and gout. Allopurinol decreases the expression of HIF-1α and HIF-2α protein. Allopurinol shows anti-depressant and anti-nociception activity. Anti-leishmanial effect [2] .
loading...
    loading...
Cat. No.: HY-P10222
Research Areas:  

Cancer

Cyclo CRLLIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 14.5 and 10.2 μM, respectively .
loading...
    loading...
Cat. No.: HY-120793
CAS No.: 1255639-43-0
Purity:  97.48%
Synonyms: TRB-N0224
Target:  

Ras Apoptosis MMP

Research Areas:  

Inflammation/Immunology Cancer

CMC2.24 (TRB-N0224), an orally active tricarbonylmethane agent, is effective against pancreatic tumor in mice by inhibiting Ras activation and its downstream effector ERK1/2 pathway. CMC2.24 is also a potent inhibitor of zinc-dependent MMPs with IC50s ranging from 2.0-69 μM. CMC2.24 alleviates osteoarthritis progression by restoring cartilage homeostasis and inhibiting chondrocyte apoptosis via the NF-κB/HIF-2α axis [2] .
loading...
    loading...
Cat. No.: HY-147426A
CAS No.: 2437257-12-8
Synonyms: ADS-007 sodium; ARO HIF2 sodium
Zifcasiran (ADS-007) sodium is an siRNA synthetic double-stranded RNAi trigger. Zifcasiran sodium selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). Zifcasiran sodium engages the cell's RNAi machinery to target HIF2α (EPAS1) mRNA for degradation, thereby reducing the amount of free HIF2α mRNA available for translation .
loading...
    loading...
Cat. No.: HY-125840R
CAS No.: 1672668-24-4
Synonyms: PT2977 (Standard); MK-6482 (Standard)
Research Areas:  

Cancer

Belzutifan (Standard) is the analytical standard of Belzutifan. This product is intended for research and analytical applications. Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC) .
loading...
    loading...
Cat. No.: HY-108697A
CAS No.: 1672662-07-5
Purity:  99.84%
Research Areas:  

Cancer

(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM .
loading...
    loading...
Cat. No.: HY-18370
CAS No.: 313964-19-1
Research Areas:  

Cancer

HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 µM and a KD of 1.1 µM. Anticancer agent .
loading...
    loading...
Cat. No.: HY-148264
CAS No.: 2511247-29-1
Synonyms: HIF-2α-IN-7; NKT2152
Imdatifan (HIF-2α-IN-7) is a hypoxia inducible factor 2α (HIF-2α) inhibitor. Imdatifan can inhibit HIF-2α with an EC50 value of 6 nM. Imdatifan can be used for the research of various types of diseases including cancer, liver disease, inflammatory disease, pulmonary diseases and iron load disorders .
loading...
    loading...
Cat. No.: HY-B0219S1
Allopurinol- 13C, 15N2 is the 13C- and 15N-labeled labeled Allopurinol (HY-B0219). Allopurinol is a potent and orally active xanthine oxidase inhibitor with an IC50 value of 0.2-50 μM. Allopurinol can be used in the research of hyperuricemia and gout. Allopurinol decreases the expression of HIF-1α and HIF-2α protein. Allopurinol shows anti-depressant and anti-nociception activity. Anti-leishmanial effect [2] .
loading...
    loading...
Cat. No.: HY-111431AR
CAS No.: 91978-69-7
Synonyms: p-Tolyl sulfate potassium (Standard)
p-Cresyl sulfate (potassium) (Standard) is the analytical standard of p-Cresyl sulfate (potassium). This product is intended for research and analytical applications. p-Cresyl sulfate (p-Tolyl sulfate) potassium is a uremic toxin, that can cause renal damage and dysfunction. p-Cresyl sulfate potassium shows antiproliferation activity. p-Cresyl sulfate potassium increases the protein expression of HIF-1α and VHL, decreases the protein expression of HIF-2α. p-Cresyl sulfate potassium induces epithelial-mesenchymal transition (EMT). p-Cresyl sulfate potassium activates the JNK and p38 MAPK signaling pathways [2] .
loading...
    loading...
Cat. No.: HY-P10223
Research Areas:  

Cancer

Cyclo CRVIIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 65 and 123 μM, respectively .
loading...
    loading...
Cat. No.: HY-130264
CAS No.: 1672666-82-8
Purity:  99.93%
Research Areas:  

Cancer

HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA) .
loading...
    loading...
Cat. No.: HY-121728
CAS No.: 1370510-16-9
Target:  

Others

Research Areas:  

Others

Langkamide is a novel hypoxia-inducible factor-2 (HIF-2) inhibitory pyrrolidone alkaloid isolated from the roots and stems of Piper sarmentosum, which inhibits HIF-2 transcriptional activity with an EC value of 14.0μM.
loading...
    loading...
Cat. No.: HY-144178
CAS No.: 2755401-07-9
Research Areas:  

Others

HIF-2α-IN-6 (117) is a HIF-2α inhibitor .
loading...
    loading...
Cat. No.: HY-144176
CAS No.: 2388500-66-9
Research Areas:  

Cancer

HIF-2α-IN-5 is a potent HIF-2α inhibitor with an IC50 of < 50 nM .
loading...
    loading...
Cat. No.: HY-163598
CAS No.: 3034589-50-6
Research Areas:  

Cancer

HIF-2α-IN-11 (1) is a HIF-2α inhibitor, with an IC50 of 59.2 nM .
loading...
    loading...
Cat. No.: HY-163597
CAS No.: 3034532-74-3
Research Areas:  

Cancer

HIF-2α-IN-10 (17) is a HIF-2α inhibitor, with an IC50 of 0.05 μM .
loading...
    loading...